Synergistic Effects of Methylglyoxal and Hyperglycemia on ROS Generation and the Viability of Cultured H9c2 Myoblast Cells by Sandhu, Robinderpal et al.
References
Synergistic Effects of Methylglyoxal and Hyperglycemia on ROS generation and the viability of cultured H9c2 Myoblast Cells 
Robinderpal Sandhu, Dylan Lefkovitz, Al Ibe, Alisa Kim,
Peter Wieczorek, Dean Delgado, Robert Barsotti, Lindon H. Young, Qian Chen
Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine
4170 City Avenue, Philadelphia, PA 19131
Introduction
Conclusions
We hypothesis that the synergistic effects of glucose (HG) and methylglyoxal
(MG) would change oxidative stress, and possibly induce cell death as
compared to individual treatments of each compound. Additionally, we will
further test if metformin (Met) can decrease MG/HG individually or co-
treatment induced cell malfunction.
The data suggest that higher concentrations of methylglyoxal, not glucose,
induces H9c2 cell damage and metformin can protect cells from the
methylglyoxal insult possibly by reduction of ROS production. Moreover,
hyperglycemia and methylglyoxal tend to induce additive cell damage
associated with increased ROS production. Further studies will examine the
effect of both compounds on ATP levels, AGE levels, and mechanism of cell
death.
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Diabetes mellitus is a disease characterized by abnormally high blood glucose 
levels (fasting levels ˃ 7mmol/l). It has been found to be closely associated with 
increased incidence of heart failure without hypertension, coronary artery disease, 
and other comorbidities (1). The deleterious effects of diabetic conditions in the heart 
hasn’t been fully understood. This study will focus on the possible synergistic effects 
of glucose and methylglyoxal on cardiomyocytes. 
A principal condition of diabetes is hyperglycemia which leads to increased 
intracellular levels of glucose metabolism associated with formation of 
mitochondrial reactive oxygen species (ROS) (2). Chronic complications stem from 
two main processes: nonenzymatic glycation and osmotic damage (Figure 1). 
Another principal condition of diabetes is increased methylglyoxal levels (2). 
Methylglyoxal is a highly reactive carbonyl, and is considered highly cytotoxic to 
the body (Figure 2). It has the ability to modify other proteins which can lead to the 
development of advanced glycation endproducts (AGE) which are involved in the 
pathogenesis of vascular problems in conditions such as diabetes (3).
Literature has suggested the synergistic effects of high glucose and 
methylglyoxal have adverse effects on cell viability, ROS generation, and ATP 
production in human mononuclear cells, human umbilical vein endothelial cells and 
endothelial progenitor cells, yet the effects remain to be elucidated in H9c2 
Myoblasts.  
Methods
H9c2 Cell Preparation: Rat H9c2 were obtained from American Type 
Culture Collection (ATCC, CRL-1446). Collection cells were maintained in 
75 cm² flasks and petri dishes using 4.5 g/mL glucose Dulbecco’s Modified 
Eagle Medium (DMEM, Corning) with 10% fetal bovine serum (FBS, 
Corning) and 1% penicillin streptomycin solution (Corning) at 37°C and 5% 
CO2 in an incubator. Once the cells are at 70-80% confluence, the cells were 
harvested using trypsin-EDTA (Sigma-Aldrich) (3 mL/flask and 2 mL/ dish). 
Cell Density was counted using trypan blue .3% kit (Sigma-Aldrich) and 
seeded into 96-well plates to obtain 2-3 x 104 cell/well
Measurement of H9c2 cell viability after HG/MG/Met Treatment: H9c2 
rat myoblasts were subjected to different doses of glucose and/or 
methylglyoxal and/or metformin and incubated for 24 hours to evaluate the 
dose-response effects on cell viability. Cell viability was determined by 
measuring absorbance at 450 nm after adding tetrazolium as instructed by 
CCK8 kit (Dojindo Molecular Technologies, Inc).
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Figure 4a: Effects of glucose (HG) on cell viability. There 
was  no statistical difference of cell viability between the 
control group and glucose groups (5 mM-40 mM). 
Figure 4b: Effects of glucose (HG) on ROS generation. 
There was  no statistical difference of ROS generation 
between the control group and the glucose group (5 
mM-40 mM). 
Figure 5a: Effects of methylglyoxal (MG) on 
cell viability. Higher methylglyoxal 
significantly reduced cell viability at doses of 
1000 µM (51 ± 8%), 1200 µM (41 ± 5%), 
and 1400 µM (36 ± 8%) compared to control 
cells. *p < 0.05 vs. control   
Figure 5B: Effects of methylglyoxal (MG) 
on ROS generation. Higher methylglyoxal 
significantly increased ROS generation at 
doses of 1000 µM (167 ± 27%); 1200 µM 
(204 ± 22%); and 1400 µM (201 ± 15%) 
compared to control cells. *p < 0.05 vs. 
control    
Figure 6a: Effects of Metformin (1 mM-40 mM) on 
methylglyoxal (MG 1200 µM) caused cell death. 
Metformin doses (10 mM-40 mM) significantly 
increased cell viability compared to methylglyoxal. 
*p<0.05 compared to methylglyoxal.
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Figure 4: Cotreatment effects of HG (40 mM) + MG (600 µM 
– 1400µM) on cell viability (n=5). An additive effect was seen 
in all doses.  
Figure 4: Cotreatment effects of HG (40 mM) + MG (600 µM 
– 1400µM) on ROS generation (n=4). An additive effect was 
seen in all doses.  
Figure 6b: Effects of Metformin (1 mM-40 mM) on 
methylglyoxal (MG 1200 µM) caused ROS 
generation. Metformin (10 mM – 20 mM) 
significantly decreased ROS generation compared 
to methylglyoxal. *p<0.05 compared to 
methylglyoxal 
Results	
Measurement of H9c2 ROS generation after HG/MG/Met Treatment: 
H9c2 rat myoblasts were incubated with 25 µM non-fluorescent and cell 
permeable dichlorofluorescein diacetate (DCFDA) for 45 minutes. After 
washing out DCFDA from incubation buffer, cells were subjected to 
incubation of different doses of glucose and/or methylglyoxal and/or 
metformin.  After 24 hours of treatments, intracellular ROS generation 
oxidizes DCFDA to a fluorescent DCF and was measured at excitation of 
480 nm, and emission at 520 nm by using Fluroskan Ascent CF scanner 
(Thermo Scientific, Inc).
Statistical Analysis: All experiments were performed in triplicate and 
repeated at least three times. All values are presented as a mean ± SEM. 
Data was analyzed using one-way ANOVA followed by Student-Newmann-
Kewls post hoc. Values of p<0.05 were considered statistically significant.  
Methods	
Figure 1: Cellular response to elevated glucose levels (4) Figure 2: Cellular response to elevated methylglyoxal levels (5)
Control Cells
HG 40 mM 
MG 1200 µM
MG 1200 µM + 
Metformin 20mM
Figure 3: pictures of H9c2 cells 
after different treatments for 24 
hours(10x). Compared to control 
cell, HG (40 mM) did not cause 
visible cell damage. By contrast, 
MG (1200 µM) showed obvious 
cell death, whereas Met (20 mM) 
protected the cells from MG-
induced cell death .
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